Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38

Cell Reports(2024)10.1016/j.celrep.2024.114502Source: DataRank Database

Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38 is a research paper published in Cell Reports (2024). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

Linked data & code

cellosaurus gen emdb refseq uniprot pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.96)OA: goldTopics (60)IDs (PubMed, PMC, OpenAlex)Annotations (6)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (27)

Stephanie R. Monticelli ORCID,Christy K. Hjorth ORCID,Vladlena Hornet ORCID,Michael P. Doyle ORCID,Dafna M. Abelson ORCID

Live enrichment

PubMed:39002130 PMC:PMC11346345 OpenAlex:https://openalex.org/W4400605935

NIAID NIH HHS

Grant: R01 AI152246

NIAID NIH HHS

Grant: U19 AI142777

National Institutes of Health

Grant: 5U19AI142777-04

Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral Threats

National Institutes of Health

Grant: 1R01AI152246-01

Structure-based Vaccine Design for CCHFV

FWCI

3.96

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.celrep.2024.114502

publisherhttps://doi.org/10.1016/j.celrep.2024.114502

publisherhttps://api.elsevier.com/content/article/PII:S2211124724008313?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124724008313?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39002130

Fields of Study

Viral Infections and VectorsViral Infections and Outbreaks ResearchMosquito-borne diseases and control0301 basic medicine03 medical and health sciencesHumansAnimalsHemorrhagic Fever, CrimeanHemorrhagic Fever Virus, Crimean-CongoAntibodies, ViralMiceSurvivorsAntibodies, NeutralizingFemaleGlycoproteinsEpitopes

MeSH Terms

AnimalsAntibodies, ViralEpitopesHemorrhagic Fever Virus, Crimean-CongoFemaleGlycoproteinsHemorrhagic Fever, CrimeanHumansSurvivorsMiceAntibodies, Neutralizing

Keywords

AntibodyVirologyGlycoproteinAntigenAntibody RepertoireBiologyImmunologyNeutralizing antibodyAntibody responseGeneticsHuman monoclonal antibodyViral GlycoproteinAntibody TherapeuticsTickborneCchfvCrimean-congo Hemorrhagic Fever VirusGp38Cp: ImmunologyNairoviridaeQH301-705.5Antibodies, ViralAntibodies, NeutralizingArticleMiceEpitopesHemorrhagic Fever Virus, Crimean-CongoHumansAnimalsHemorrhagic Fever, CrimeanFemaleSurvivorsBiology (General)Glycoproteins

Sustainable Development Goals

SDG 3: 3. Good health

Crimean-Congo hemorrhagic fever survivors elicit protective non-neutralizing antibodies that target 11 overlapping regions on glycoprotein GP38

FAIR Checklist

Authors (27)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)